Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
1978
ISSN/ISBN: 0070-4067 PMID: 84448 Document Number: 133983
Document emailed within 1 workday
Related Documents
Glińska, H.; Papla, B.; Siuda, M.; Zulichowska, J. 1989: Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma Przeglad Lekarski 46(11): 757-761Dura, W.T.; Wichrzycka, E.; Woźniewicz, B.; Gładkowska-Dura, M.; Cieślak, H. 1979: Non-Hodgkin lymphoma in developmental age (morphological analysis and prognostic factors based on the Kiel classification) Patologia Polska 30(3): 329-360
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Fedder, G.; Somers, R. 1982: Non-Hodgkin lymphoma following radio- and chemotherapy of Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 126(38): 1730-1733
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Horikoshi, N.; Inagaki, J.; Ogawa, M. 1983: Chemotherapy for advanced non-Hodgkin's lymphoma with CVP therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(8): 1885-1891
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Ohnoshi, T.; Hayashi, K.; Mizuta, J.; Tagawa, S.; Matsutomo, S.; Saito, S.; Kawashima, K.; Akagi, T.; Kimura, I. 1993: Brief induction chemotherapy followed by involved-field irradiation for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma International Journal of Hematology 57(1): 61-66
Portlock, C.S.; Fischer, D.S.; Cadman, E.; Lundberg, W.B.; Levy, A.; Bobrow, S.; Bertino, J.R.; Farber, L. 1987: High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma Cancer Treatment Reports 71(11): 1029-1031
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Goss, P.E.; Burkes, R.; Rudinskas, L.; King, M.; Chow, W.; Myers, R.; Davidson, M.; Poldre, P.; Crump, M.; Sutton, D. 1994: Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report Seminars in Hematology 31(2 Suppl. 3): 23-29
Libura, J.; Bettens, F.; Radkowski, A.; Tiercy, J-Marie.; Piguet, P.F. 2002: Polymorphic tumor necrosis factors microsatellite TNFa4 is associated with resistance of Hodgkin lymphoma to chemotherapy and with replapses after therapy Anticancer Research 22(2a): 921-926
Masaki, N.; Ikeda, H.; Hayabuchi, N.; Niibe, H.; Kaneta, H.; Morita, K.; Horiuchi, J.; Watanabe, S. 1988: Results of radiation therapy of stage I-II non-Hodgkin's lymphoma localized in the head and neck--a report of the Japanese Lymphoma Radiation Therapy Study Group Gan no Rinsho. Japan Journal of Cancer Clinics 34(5): 581-588
Masaki, N.; Ikeda, H.; Kaneta, K.; Morita, K.; Niibe, H.; Watanabe, S.; Hayabuchi, N.; Horiuchi, J. 1988: Results of radiation therapy of stage II non-Hodgkin's lymphoma of the Waldeyer's ring: a report of the Japanese Lymphoma Radiation Therapy Study Group Gan no Rinsho. Japan Journal of Cancer Clinics 34(5): 612-618
Urasiński, I.; Urasiński, T.; Krygier-Stojałowska, A. 1994: Survival of patients and DNA-ploidy of cells in non-Hodgkin's lymphoma of low-grade malignancy Acta Haematologica Polonica 25(4): 355-361
Lambert, J.; Wijermans, P.W.; Dekker, G.A.; Ossenkoppele, G.J. 1991: Chemotherapy in non-Hodgkin's lymphoma during pregnancy Netherlands Journal of Medicine 38(1-2): 80-85
Ristić, S.; Jovanović, V.; Ristić, S.; Radojković, M. 1996: Non-Hodgkin's lymphoma: morphologic, immunologic and cytogenetic classification Srpski Arhiv Za Celokupno Lekarstvo 124(9-10): 276-282
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Yazici, H.; Saip, P.; Inanç, S.; Onat, H.; Dalay, N. 1998: Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphoma Research Communications in Molecular Pathology and Pharmacology 100(3): 301-311
Telek, B.; Pecze, K.; Kiss, A.; Rák, K. 1984: Cytochemical analysis of acid phosphatase and beta glucuronidase in B-cell non-Hodgkin's lymphoma of low-grade malignancy Orvosi Hetilap 125(4): 189-192